Viewing
News|Articles|June 25, 2025

Three-year outcomes of aflibercept 8mg in neovascular age related macular degeneration and diabetic macular edema

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe

Latest CME